Elevated lipoprotein(a) is an established independent risk for cardiovascular disease, stroke, peripheral artery disease, and calcific aortic valve disease. This session will provide education for health care professionals on genetics and the importance of measuring Lp(a) levels. Leading experts will address comprehensive clinical recommendations to incorporate patient-centered care for diagnosing, treating, and managing patients with elevated Lp(a).